MedQuist Holdings, the largest US provider of medical transcription services, raised $36 million on Thursday by offering 4.5 million shares at $8, below the $10 to $12 proposed range. The company also sold 43% fewer shares than the originally-proposed 7.8 million. MedQuist Holdings will list on the NASDAQ under the symbol MEDH. Lazard Capital Markets, Macquarie Capital, and RBC Capital Markets acted as lead managers on the deal.
